Build status - In Progress

API Push Trial without Cancer condition at attribute

Study on Diffuse Glioma and Investigational Medication

Recruiting
99 years or below
All
Phase N/A
2 Locations

Brief description of study

To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource
utilization.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

This study investigates the efficacy of an investigational medication in participants with diffuse glioma. The purpose is to understand how the medication works after radiotherapy and its effects on the tumor.

The study focuses on evaluating the treatment's impact on health care resource use and measuring plasma concentrations to estimate pharmacokinetic parameters.

  • Who can participate: Eligibility criteria are to be determined. Key factors will include age, diagnosis of diffuse glioma, and overall health status.
  • Study details: Participants will take the investigational medication. The study will measure how the medication affects the tumor and health care resource use.
Updated on 30 Apr 2026. Study ID: 20260407-4

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center